Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06253637
Title Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program (DARATALL-VHR)
Acronym DARATALL-VHR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Ematologia AOU Careggi RECRUITING Firenze Italy Details
Ematologia P.O. Vito Fazzi - Lecce RECRUITING Lecce Italy Details
Ematologia AOU Policlinico Umberto I RECRUITING Roma Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field